Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Giladi

Showing results (31-40 of 114) with videos related to

Pageof 12
Sort By:
Journal of Neural Transmission (Vienna, Austria : 1996)|November 5, 2008
Treadmill training for the treatment of gait disturbances in people with Parkinson's disease: a mini-reviewT Herman, N Giladi, J M Hausdorff
Harefuah|July 7, 2000
[Botulin toxin for spasticity in spinal cord damage by treating the motor endplate]O Keren, F Shinberg, A Catz, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 29, 2000
An open trial of amantadine and buspirone for cerebellar ataxia: a disappointmentS Hassin-Baer, A D Korczyn, N Giladi
Parkinsonism & Related Disorders|March 15, 2001
Gait festination in Parkinson's diseaseN Giladi, H Shabtai, E Rozenberg, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|March 24, 2005
Quality of life and gender identity in Parkinson's diseaseO Moore, S Kreitler, M Ehrenfeld, et al.
Brain : a Journal of Neurology|June 9, 2009
Differential phenotype in Parkinson's disease patients with severe versus mild GBA mutationsZ Gan-Or, N Giladi, A Orr-Urtreger
Journal of Neural Transmission (Vienna, Austria : 1996)|January 10, 2004
Parkin mutation associated parkinsonism and cognitive decline, comparison to early onset Parkinson's diseaseB R Benbunan, A D Korczyn, N Giladi
Neuroepidemiology|December 18, 2001
Cross-sectional study of the prevalence of Parkinson's disease in the Kibbutz movement in IsraelM Anca, D Paleacu, H Shabtai, et al.
Biochemical Pharmacology|February 20, 2014
Nucleoside 5'-phosphorothioate derivatives are highly effective neuroprotectantsO Danino, N Giladi, S Grossman, et al.
European Neurology|October 29, 2000
Long-term remission of idiopathic cervical dystonia after treatment with botulinum toxinN Giladi, J Meer, H Kidan, et al.
Pageof 12

Showing results (31-40 of 114) with videos related to

Sort By:
Pageof 12
Journal of Neural Transmission (Vienna, Austria : 1996)|November 5, 2008
Treadmill training for the treatment of gait disturbances in people with Parkinson's disease: a mini-reviewT Herman, N Giladi, J M Hausdorff
Harefuah|July 7, 2000
[Botulin toxin for spasticity in spinal cord damage by treating the motor endplate]O Keren, F Shinberg, A Catz, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 29, 2000
An open trial of amantadine and buspirone for cerebellar ataxia: a disappointmentS Hassin-Baer, A D Korczyn, N Giladi
Parkinsonism & Related Disorders|March 15, 2001
Gait festination in Parkinson's diseaseN Giladi, H Shabtai, E Rozenberg, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|March 24, 2005
Quality of life and gender identity in Parkinson's diseaseO Moore, S Kreitler, M Ehrenfeld, et al.
Brain : a Journal of Neurology|June 9, 2009
Differential phenotype in Parkinson's disease patients with severe versus mild GBA mutationsZ Gan-Or, N Giladi, A Orr-Urtreger
Journal of Neural Transmission (Vienna, Austria : 1996)|January 10, 2004
Parkin mutation associated parkinsonism and cognitive decline, comparison to early onset Parkinson's diseaseB R Benbunan, A D Korczyn, N Giladi
Neuroepidemiology|December 18, 2001
Cross-sectional study of the prevalence of Parkinson's disease in the Kibbutz movement in IsraelM Anca, D Paleacu, H Shabtai, et al.
Biochemical Pharmacology|February 20, 2014
Nucleoside 5'-phosphorothioate derivatives are highly effective neuroprotectantsO Danino, N Giladi, S Grossman, et al.
European Neurology|October 29, 2000
Long-term remission of idiopathic cervical dystonia after treatment with botulinum toxinN Giladi, J Meer, H Kidan, et al.
Pageof 12